is tirzepatide wegovy F.D.A. Approves New Obesity Drug That Will Compete With Diabetes drug tirzepatide linked to

#DYK 58 million people with commercial insurance are eligible for GLP-1 therapies, based on current FDA approvals

For clinicians and patients, this is a moment of transition

Results PH is driven by multifactorial mechanisms, including exaggerated insulin secretion, incretin overproduction (GLP-1, GIP), altered glucose absorption, and autonomic dysfunction

The starting dose of Mounjaro is 2.5 mg once weekly for the first four weeks, which allows your body to adjust gradually and reduces the risk of gastrointestinal side effects. After four weeks, the dose is typically increased to 5 mg once weekly, with further increases in 2.5 mg steps every four weeks as tolerated. The maximum approved dose is 15 mg once weekly